Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

Cecere SC;Giannone G;Salutari V;Arenare L;Lorusso D;Ronzino G;Lauria R;Cormio G;Carella C;Scollo P;Ghizzoni V;Raspagliesi F;Di Napoli M;Mazzoni E;Marchetti C;Bergamini A;Orditura M;Valabrega G;Scambia G;Maltese G;De Matteis E;Cardalesi C;Loizzi V;Boccia S;Naglieri E;Scandurra G;Pignata S

2020-01-01